S.H. van Rijt

He, L., Habibovic, P., & van Rijt, S. (2025). Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment. Journal of Controlled Release, 388, Article 114289. https://doi.org/10.1016/j.jconrel.2025.114289

de Theije, C. G. M., De Palma, S. T., Vaes, J. E. G., Dallaglio, K., Volpi, G., Ardigo, D., van Rijt, S., van Bel, F., Benders, M. J. N. L., & Nijboer, C. H. A. (2025). Intranasal Wharton's Jelly-Derived Mesenchymal Stem Cell Therapy, Alone or in Conjunction With Therapeutic Hypothermia, Alleviates Neonatal Hypoxic-Ischemic Brain Injury in Mice. Annals of Neurology, 98(6), 1380-1394. https://doi.org/10.1002/ana.78000

Weng, H., Decarli, M. C., He, L., Chen, W., van Rijt, S., Bernaerts, K. V., & Moroni, L. (2025). Mechanical Reinforced and Self-healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide-Xanthan Gum Constructs for Ligament Regeneration. Advanced Healthcare Materials, 14(25), Article 2502341. https://doi.org/10.1002/adhm.202502341

De Palma, S. T., Hermans, E. C., Shamorkina, T. M., Trayford, C., van Rijt, S., Heck, A. J. R., Nijboer, C. H. A., & de Theije, C. G. M. (2025). Hypoxic Preconditioning Enhances the Potential of Mesenchymal Stem Cells to Treat Neonatal Hypoxic-Ischemic Brain Injury. Stroke, 56(7), 1872-1882. https://doi.org/10.1161/STROKEAHA.124.048964

He, L., Javid Anbardan, Z., Habibovic, P., & van Rijt, S. (2025). pH- and redox-sensitive selenium-incorporated mesoporous silica nanoparticles for osteosarcoma-targeted treatment. Materials & design, 253, Article 113883. https://doi.org/10.1016/j.matdes.2025.113883

Smeets, L. C. C., Sengun, E., Trayford, C., van Cranenbroek, B., de Jonge, M. I., Dallaglio, K., Hutten, M. C., Schoberer, M., Ophelders, D. R. M. G., Wolfs, T. G. A. M., van der Molen, R. G., & van Rijt, S. (2025). Gold Mesoporous Silica-Coated Nanoparticles for Quantifying and Qualifying Mesenchymal Stem Cell Distribution; a Proof-of-Concept Study in Large Animals. ACS Applied Bio Materials, 8(2), 1511-1523. https://doi.org/10.1021/acsabm.4c01714

He, L., Anbardan, Z. J., Habibovic, P., & van Rijt, S. (2024). Doxorubicin- and Selenium-Incorporated Mesoporous Silica Nanoparticles as a Combination Therapy for Osteosarcoma. ACS Applied Nano Materials, 7(22), 25400 - 25411. https://doi.org/10.1021/acsanm.4c04294

Zengin, A., Hafeez, S., Habibovic, P., Baker, M., & van Rijt, S. (2024). Extracellular matrix mimetic supramolecular hydrogels reinforced with covalent crosslinked mesoporous silica nanoparticles. Journal of Materials Chemistry. B, Materials for Biology and Medicine, 12(48), 12577-12588. https://doi.org/10.1039/d4tb00499j

Trayford, C., & van Rijt, S. (2024). In situ modified mesoporous silica nanoparticles: synthesis, properties and theranostic applications. Biomaterials Science, 12(21), 5450-5467. https://doi.org/10.1039/d4bm00094c

Zhang, X., van Veen, S., Hadavi, D., Zhao, Y., Mohren, R., Habibovic, P., Honing, M., Albertazzi, L., & van Rijt, S. (2024). DNA Nanoparticle Based 2D Biointerface to Study the Effect of Dynamic RGD Presentation on Stem Cell Adhesion and Migration. Small, 20(37), Article 2311402. https://doi.org/10.1002/smll.202311402